Skip to main content

Closed

COYA: Coya Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-40.8% / yr

Operating margin-277.0%

ROIC-44.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio15.02×

Coya Therapeutics, Inc.

COYANASDAQ Capital Market·USD·Closed

Coya Therapeutics, Inc.

COYANASDAQ·USD·Closed

$4.19

+2.70%

$4.19

+$0.11 (2.70%)

52W Range

12thpctl

Volume

0.85×avg

Mkt Cap

76.29MUSD

P/E

-3.6TTM

Div Yield

–ann

52W Range

12thpctl

Volume

0.85×avg

Market Cap

76.29MUSD

P/E Ratio

-3.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings